Skip to content

Opening book details…

About this Medicine article

Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial by Avettand-Fenoel, V.; Flandre, P.; Chaix, M. L.; Ghosn, J.; Delaugerre, C.; Raffi, F.; NgoVan, P.; Cohen-Codar, I.; Delfraissy, J. F.; Rouzioux, C. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Avettand-Fenoel, V.; Flandre, P.; Chaix, M. L.; Ghosn, J.; Delaugerre, C.; Raffi, F.; NgoVan, P.; Cohen-Codar, I.; Delfraissy, J. F.; Rouzioux, C.
Publisher
Oxford University Press; Oxford University Press (OUP) (ISSN 0305-7453)
Published
2010
Language
EN
Field
Medicine (Health Sciences)

More by Avettand-Fenoel, V.; Flandre, P.; Chaix, M. L.; Ghosn, J.; Delaugerre, C.; Raffi, F.; NgoVan, P.; Cohen-Codar, I.; Delfraissy, J. F.; Rouzioux, C.

Browse all works by Avettand-Fenoel, V.; Flandre, P.; Chaix, M. L.; Ghosn, J.; Delaugerre, C.; Raffi, F.; NgoVan, P.; Cohen-Codar, I.; Delfraissy, J. F.; Rouzioux, C.